1802632-22-9
1802632-22-9
Chemical Structure
Zervimesine
Synonym(s): CT1812; Sigma-2 receptor antagonist 1
- CAS No.: 1802632-22-9
- Formula:C24H33NO4S
- Molecular Weight:431.59
IUPAC Name: 2-(tert-butoxy)-4-(3-methyl-3-(5-(methylsulfonyl)isoindolin-2-yl)butyl)phenol
InChIKey: ISQAPFMBJFZOLG-UHFFFAOYSA-N
SMILES: OC1=CC=C(CCC(C)(N2CC3=C(C=C(S(=O)(C)=O)C=C3)C2)C)C=C1OC(C)(C)C
Biological Activity: Zervimesine (CT1812) is an orally active and brain penetrant sigma-2 receptor antagonist with a Ki of 8.5 nM. Zervimesine can be used for the research of Alzheimer’s disease[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zervimesine | 99.01% | Zervimesine (CT1812) is an orally active and brain penetrant sigma-2 receptor antagonist with a Ki of 8.5 nM. Zervimesine can be used for the research of Alzheimer’s disease. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
